Resource Investing NewsPrecious Metals InvestingBase Metals InvestingBattery Metals InvestingTechnology Investing NewsCannabis Investing NewsCompany NewsFeaturedInterviewsINNvestor ReportsAustralian CompaniesAbout INNINN Contributorsuranium investing
See our exclusive index of companies on the move:
Explore Stocks- Top Stocks
- Top Australian Gold Stocks
- Top ASX Copper Stocks
- Top ASX Nickel Stocks
- Top ASX Rare Earth Stocks
- Top Battery Metals Stocks on the ASX
- Top Australian Lithium Stocks
- Top Graphite Miners on the ASX
- 10 ASX Cannabis Stocks
- Top ASX Tech Stocks
- Top AI Stocks on the ASX
- On Site
- About Australian Cannabis Investing
- About Australian Resource Investing
- About Australian Tech Investing
- About Australia Investing
- Of Interest
- ASEAN-Australia-New Zealand Trade Agreement
- Association of Southeast Asian Nations (ASEAN)
- Australian FAQ on ASEAN
- Australia Government on Foreign Investments
Copyright 2021 All Rights Reserved.
MGC Pharmaceuticals issued a notice for its annual general meeting set to take place on November 29, 2019.
MGC Pharmaceuticals (ASX:MXC) issued a notice for its annual general meeting set to take place on November 29, 2019.
As quoted in the press release:
The resolutions in the Notice of Meeting address the following key items of business:
- Adoption of Remuneration Report, Re-election of Directors, Approval of 10 percent Placement Capacity
- Appointment of New Company Auditor – Ernst & Young
- Issue of Related Party Performance Rights to Directors following new service agreements entered into and announced in January 2019, and detailed in the 2019 Annual Report
- Ratification of Prior Share and Option Issues, Issue of Options, New ASX & ASIC Compliant Incentive Performance Rights Plan
Featured
Global News
Top News
FEATURED STOCKS
Investing News Network websites or approved third-party tools use cookies. Please refer to the cookie policy for collected data, privacy and GDPR compliance. By continuing to browse the site, you agree to our use of cookies.